1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MEC 10-2-088, NCT01358045
|
|
2.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000565063, RPCI-I-68905, I 68905, NCT00536991
|
|
3.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 004253, NCT00445250
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 30 to 65
Sponsor: Other
Protocol IDs: P-09-00171, NCT01039181
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 88
Sponsor: Other
Protocol IDs: 25741, NCT01293682
|
|
6.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: CDR0000596506, P30CA016056, RPCI-I-90206, I 90205, NCT00690924
|
|
7.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: I 163509, NCI-2010-00263, NCT01093092
|
|
8.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: FMUSPIBCCVD2009, CAPPesq 626/06, FAPESP 07/04799-2, IBCC 108/2006/07, CAPPesq 0018/09, NCT00926315
|
Mobile | Español
